Vaccinum adsorbatum: hepatitis-A-virus inactivatus (HM175) 1440 U. corresp. proteina max. 0.4 µg, aluminii hydroxidum hydricum ad adsorptionem corresp. aluminium 0.5 mg, aminoacida cum phenylalaninum 166 µg, dinatrii phosphas, kalii dihydrogenophosphas, natrii chloridum, kalii chloridum, polysorbatum 20, aqua ad iniectabile, ad suspensionem pro 1 ml corresp. natrium max. 3.6 mg et kalium max. 0.5 mg, residui: neomycini sulfas.
Packungsbestandteile
Injection suspension
Active Agent
Dose
additional_information
Hepatitis-A-Virus Inactivatus (Hm175)
1440 U/ml correspond Protein 0.4 µg/ml
Vaccinum adsorbatum
Inactive agents
Dose
Aluminii Hydroxidum Hydricum ad Adsorptionem
Aminoacida cum Phenylalaninum
166 µg/ml
Disodium Phosphate
Potassium Chloride
Potassium Dihydrogenophosphate
Sodium Chloride
Polysorbatum 20
Source
Data was imported : 08.08.2023
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
